ScholarIQanswers from OpenAlex

A Prospective Open-Label Treatment Trial of Olanzapine Monotherapy in Children and Adolescents with Bipolar Disorder

PaperCitations, authors & open-access status

A Prospective Open-Label Treatment Trial of Olanzapine Monotherapy in Children and Adolescents with Bipolar Disorder is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A Prospective Open-Label Treatment Trial of Olanzapine Monotherapy in Children and Adolescents with Bipolar Disorder have?

ScholarIQcitation count

A Prospective Open-Label Treatment Trial of Olanzapine Monotherapy in Children and Adolescents with Bipolar Disorder has 247 citations in the OpenAlex counts ScholarIQ stores.

When was A Prospective Open-Label Treatment Trial of Olanzapine Monotherapy in Children and Adolescents with Bipolar Disorder published?

ScholarIQyear

A Prospective Open-Label Treatment Trial of Olanzapine Monotherapy in Children and Adolescents with Bipolar Disorder has 2001 year in the ScholarIQ index.

What is the open-access status of A Prospective Open-Label Treatment Trial of Olanzapine Monotherapy in Children and Adolescents with Bipolar Disorder?

ScholarIQoa status

A Prospective Open-Label Treatment Trial of Olanzapine Monotherapy in Children and Adolescents with Bipolar Disorder has closed oa status in the ScholarIQ index.

What is the DOI of A Prospective Open-Label Treatment Trial of Olanzapine Monotherapy in Children and Adolescents with Bipolar Disorder?

ScholarIQdoi

The DOI for A Prospective Open-Label Treatment Trial of Olanzapine Monotherapy in Children and Adolescents with Bipolar Disorder is on the source record.

What is the PMID of A Prospective Open-Label Treatment Trial of Olanzapine Monotherapy in Children and Adolescents with Bipolar Disorder?

ScholarIQpmid

The PMID for A Prospective Open-Label Treatment Trial of Olanzapine Monotherapy in Children and Adolescents with Bipolar Disorder is on the source record.

What is the OpenAlex record for A Prospective Open-Label Treatment Trial of Olanzapine Monotherapy in Children and Adolescents with Bipolar Disorder?

ScholarIQopenalex

The OpenAlex for A Prospective Open-Label Treatment Trial of Olanzapine Monotherapy in Children and Adolescents with Bipolar Disorder is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial